Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Chimerix Q2 2024 GAAP EPS $(0.23), Inline, Sales $129.000K Beat $62.500K Estimate

Author: Benzinga Newsdesk | August 13, 2024 07:05am
Chimerix (NASDAQ:CMRX) reported quarterly losses of $(0.23) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $129.000 thousand which beat the analyst consensus estimate of $62.500 thousand by 106.40 percent. This is a 396.15 percent increase over sales of $26.000 thousand the same period last year.

Posted In: CMRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist